Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 9,589 calls trading, 1.6x expected, and implied vol increasing over 27 points to 135.16%. Jan-26 10 calls and 4/11 weekly 6 calls are the most active options, with total volume in those strikes near 19,100 contracts. The Put/Call Ratio is 0.12. Earnings are expected on May 8th.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Recursion Pharmaceuticals price target lowered to $8 from $10 at Morgan Stanley
- Recursion Pharmaceuticals, Enamine release new tools in its AI/ML platform
- Recursion announces first patient dosed in Phase 1 REC-3565 study
- Strategic Positioning and Operational Resilience Justify Buy Rating for Recursion Pharmaceuticals
- Recursion Pharmaceuticals call volume above normal and directionally bullish